A Leap Forward in Asthma Management with AI

By Danélia Botes

January 2, 2024

The Asthma Challenge

The chronic disease known as asthma, which is characterised by inflammation of the airways, affects between 10 and 12 percent of children around the world and a sizeable percentage of adults. It is the ailment that affects children the most frequently and is a big contributor to the burden of health problems all around the world. In order to alleviate the enormous physical and financial burden that asthma exacerbations impose, it is essential to diagnose the condition at an early stage and to manage it effectively.

The Role of Artificial Intelligence in Asthma Management

The use of artificial intelligence (AI) in healthcare has been a topic of interest for the past few years as this could be utilised to manage or prevent several diseases. Research on the AI-assisted home stethoscope, StethoMe, reveals its potential for detecting and monitoring asthma, particularly in children. This device can identify pathological auscultatory phenomena. It also measures parameters like heart rate, respiratory rate, and the ratio of inspiration-to-expiration duration.

AI-aided Stethoscope: A Game Changer in Asthma Monitoring

The study found that the parameters provided by the AI-aided stethoscope alone were highly efficient in identifying asthma exacerbation in children. This indicates that AI-aided stethoscopes can facilitate the detection of exacerbations with high effectiveness. Even in children younger than five years of age. This is a significant advancement as asthma management in children is challenging due to the limitations of conducting standard physiologic tests.

The Future of AI in Asthma Management

The use of AI-aided stethoscopes in asthma management aligns with the shift towards value-based healthcare. AI-aided stethoscopes are a useful tool that can optimise and improve patient-doctor collaboration using telemedicine solutions. They also have the potential to improve asthma-related health outcomes, increase access to care, and offer cost-effectiveness. The study indicates that home stethoscopes, aided by AI, could simplify asthma diagnosis. They could monitor a wider range of parameters and significantly ease the process of asthma monitoring.

Reference url

Recent Posts

Cutaneous Malignant Melanoma Treatment
        

Forecasting Innovations in Cutaneous Malignant Melanoma Treatment in Sweden

“Shaping Melanoma Care: Insights for UV Safety Month”

🌟 Exciting Insights! Learn how system dynamics modelling shapes the future of cutaneous malignant melanoma care during UV Safety Month. Discover key strategies for better healthcare planning and patient outcomes. #SyenzaNews #UVSafetyMonth #HealthcarePlanning #MelanomaCare #PreventiveInterventions 🏥

skin cancer primary prevention
           

Enhancing Skin Cancer Prevention in a Primary Care Setting

🌞 Discover the latest strategies in skin cancer primary prevention! From innovative risk assessment tools to new technologies, learn how primary care can play a pivotal role in reducing skin cancer rates.
🩺👩‍⚕️👨‍⚕️ #SyenzaNews #Healthcare #SkinCancerPrevention #PrimaryCare #Innovation

Valvular heart disease in Saudi Arabia
           

Addressing Valvular Heart Disease in Saudi Arabia

#SyenzaNews 🚀 Valvular heart disease (VHD) is a growing concern in Saudi Arabia, especially among the ageing population.
Discover the current challenges and actionable recommendations to enhance VHD care.

Let’s work together to improve awareness, detection, and treatment! #Healthcare #Cardiology #SaudiArabia #HealthyAging 🌟

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.